Skip to main content Skip to main navigation menu Skip to site footer
Revista de la Facultad de Medicina

Vol. 1 No. 35 (2023)

Familial Ataxia-Telangiectasia: A case series

Case reports
Published: 2023-11-20

Abstract

Ataxia telangiectasia (A-T) is an autosomal recessive disease (OMIM #208900) with severe neurological involvement typically with cerebellar ataxia as the first presenting symptom.  It is caused by a mutation in the ataxia telangiectasia mutated (ATM) gene that results in a protein that impairs the repair of damaged DNA. It does not depend on race or ethnicity, affecting males and females equally. However, consanguinity significantly increases its incidence. This is a descriptive observational study of case report type, its objective is to present three siblings with Ataxia Telangiectasia, a brief description of A-T and how these patients exemplify the presentation of A-T along different ages in the same family.

References

  1. Rothblum-Oviatt, C., Wright, J., Lefton-Greif, M.A., McGrath-Morrow, S.A., Crawford, T.O., Lederman, H.M. Ataxia telangiectasia: a review. Orphanet J Rare Dis. 2016, Nov.; 11(1): 159. https://doi.org/10.1186/s13023-016-0543-7 DOI: https://doi.org/10.1186/s13023-016-0543-7
  2. Amirifar, P., Ranjouri, M.R., Yazdani, R., Abolhassani, H., Aghamohammadi, A. Ataxia-telangiectasia: A review of clinical features and molecular pathology. Pediatric allergy and immunology: official publication of the European Society of Pediatric Allergy and Immunology. 2019, May ; 30(3): 277–288. https://doi.org/10.1111/pai.13020 DOI: https://doi.org/10.1111/pai.13020
  3. Mitiagin, Y., Barzilai, A. Ataxia-telangiectasia mutated plays an important role in cerebellar integrity and functionality. Neural Regen Res. 2023, Mar.; 18(3): 497-502, DOI: 10.4103/1673-5374.350194 DOI: https://doi.org/10.4103/1673-5374.350194
  4. Amirifar, P., Reza ,R.R., Lavin, M., Abolhassani, H., Yazdani, R., Aghamohammadi, A. Ataxia-telangiectasia: Epidemiology, Pathogenesis, Clinical Phenotype, Diagnosis, Prognosis and Management. Expert Rev Clin Immunol. 2020, Sep.; 16(9): 859-871, DOI: 10.1080/1744666X.2020.1810570 DOI: https://doi.org/10.1080/1744666X.2020.1810570
  5. Petley, E., Yule, A., Alexander, S., Ojha, S., Whitehouse, W.P. The natural history of ataxia-telangiectasia (A-T): A systematic review. PLoS ONE. 2022, March; 17(3): e0264177. DOI: 10.1371/journal.pone.0264177 DOI: https://doi.org/10.1371/journal.pone.0264177
  6. Tang, S.Y., Shaikh, A.G. Past and Present of Eye Movement Abnormalities in Ataxia-Telangiectasia. Cerebellum. 2019, Jun.; 18(3): 556–564. DOI: 10.1007/s12311-018-0990-x DOI: https://doi.org/10.1007/s12311-018-0990-x
  7. Kuo, S.H. Ataxia. Continuum. 2019, Aug.; 25(4): 1036–1054. DOI: 10.1212/CON.0000000000000753 DOI: https://doi.org/10.1212/CON.0000000000000753
  8. van Os, N.J.H., Haaxma, C.A., van der Flier, M,. Merkus, P.J.F.M., van Deuren, M., de Groot, I.J.M., et al. Ataxia-telangiectasia: recommendations for multidisciplinary treatment. Dev Med Child Neurol. 2017, July; 59(7): 680-689. https://doi.org/10.1111/dmcn.13424 DOI: https://doi.org/10.1111/dmcn.13424
  9. The Ataxia-Telegiectasia Society. Ataxia-Telangiectasia in Children : Guidance on Diagnosis and Clinical Care. 2014, Oct.; 30 pag. https://atsociety.org.uk/wp-content/uploads/2017/10/A-T_Clinical_Guidance_Document_Final.pdf.
  10. Tiet, M.Y., Horvath, R., Hensiek, A.E. Ataxia telangiectasia: what the neurologist needs to know. Practical Neurology. 2020, Oct.; 20(5): 404-414. DOI: 10.1136/practneurol-2019-002253 DOI: https://doi.org/10.1136/practneurol-2019-002253
  11. Teive, H.A., Moro, A., Moscovich, M., Arruda, W.O., Munhoz, R.P., Raskin, S. et al. Ataxia-telangiectasia - A historical review and a proposal for a new designation: ATM syndrome. J Neurol Sci. 2015, Aug.; 355(1-2): 3–6. DOI: 10.1016/j.jns.2015.05.022 DOI: https://doi.org/10.1016/j.jns.2015.05.022
  12. Neves Barreto, T.L., Rocha Raslan,I., Kakiuchi Trajano, K., Aparecida Maggi, F., Pedroso, J.L., Povoas Barsottini, O. G. Correlation between neurological features, nutritional status, and metabolic changes in patients with Ataxia-telangiectasia. Expert Opinion on Orphan Drugs. 2021, May; 9(4): 133-137. DOI: 10.1080/21678707.2021.1927701 DOI: https://doi.org/10.1080/21678707.2021.1927701
  13. Sartori, S., Ulibarrie, A., De la Peña, A., Andreolli, M. Ataxia-Telangiectasia con inmundeficiencia. Dermatología Pediatrica Latinoamericana. 2018, Abril/Junio; 13(2): 52-65. https://docs.bvsalud.org/biblioref/2022/04/982658/dermatol-ped-latinoam-2018-v13-n2-ataxia.pdf

  • Anna Yurrita
    Catedrático UFM
Palabras clave: Ataxia Telangectasias ATM

Revista de la Facultad de Medicina is an Open Access scholarly peer-reviewed journal. It aims to publish clinical research studies and clinical trials contribuiting to enrich the knowledge and development of the Medical Science. The journal is published semi-annualy by the Faculty of Medicine of Francisco Marroquin university. 

Call for papers for our following issue July - December 2022

Check if your work meet the requirements specified in the submission preparation checklist

If your work meet the requirements, register, log in y submit your work

Por favor lea todos los pasos en el arbitraje por los que tiene que pasar para llegar a la recta final

 

This work is under a Creative Commons Attribution-Non Comercial-Share Alike-4.0 Internacional License (CC BY-NC-SA 4.0)

 

 

How to Cite

Yurrita, A. (2023). Familial Ataxia-Telangiectasia: A case series. Revista De La Facultad De Medicina, 1(35), 70–78. https://doi.org/10.37345/23045329.v1i35.108